Fruquintinib is a highly selective oral tyrosine kinase inhibitor primarily indicated for the treatment of colorectal cancer, where it works by inhibiting vascular endothelial growth factor receptors (VEGFR).… Read more































Fruquintinib is a highly selective oral tyrosine kinase inhibitor primarily indicated for the treatment of colorectal cancer, where it works by inhibiting vascular endothelial growth factor receptors (VEGFR). This category provides a comprehensive selection of Fruquintinib reference standards, including impurities, metabolites, and stable isotope labelled compounds essential for rigorous pharmaceutical analysis. Laboratory professionals utilize these high-quality materials for impurity profiling, method validation, and routine quality control to ensure the integrity of the active pharmaceutical ingredient throughout the drug development lifecycle. By facilitating the accurate identification and quantification of potential degradation products and synthetic by-products, these analytical tools support compliance with stringent regulatory standards. Whether conducting stability studies or developing complex assays, researchers rely on these precise standards to maintain the efficacy and safety profile of the therapeutic compound in pharmaceutical manufacturing and research environments.